Atopic dermatitis prevention and treatment
- PMID: 29121124
Atopic dermatitis prevention and treatment
Abstract
Atopic dermatitis (AD) is the cause of substantial morbidity including severe pruritus and impaired personal and familial quality of life. Furthermore, the rising incidence and familial association of AD have highlighted the need for disease prevention. It is largely genetic in nature and cannot be avoided in all cases. However, low-risk prevention strategies have been attempted to reduce triggering of first onset of AD in predisposed individuals. Therapeutics for active disease include trigger avoidance, barrier repair, topical medicaments including topical corticosteroids (TCs) and nonsteroidal agents, phototherapy, and antibacterial interventions.
Similar articles
-
Recent Advances in Pharmacotherapeutic Paradigm of Mild to Recalcitrant Atopic Dermatitis.Crit Rev Ther Drug Carrier Syst. 2016;33(3):213-263. doi: 10.1615/CritRevTherDrugCarrierSyst.2016015219. Crit Rev Ther Drug Carrier Syst. 2016. PMID: 27910751 Review.
-
Atopic dermatitis - all you can do from the outside.Br J Dermatol. 2014 Jul;170 Suppl 1:19-24. doi: 10.1111/bjd.12957. Epub 2014 May 9. Br J Dermatol. 2014. PMID: 24720530 Review.
-
[Atopic dermatitis].Ugeskr Laeger. 2018 Jan 22;180(4):V04170331. Ugeskr Laeger. 2018. PMID: 29393034 Review. Danish.
-
Atopic dermatitis: the new frontier.Med J Aust. 2017 Oct 16;207(8):351-356. doi: 10.5694/mja17.00463. Med J Aust. 2017. PMID: 29020907 Review.
-
Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.Br J Dermatol. 2008 May;158(5):1083-93. doi: 10.1111/j.1365-2133.2008.08484.x. Epub 2008 Mar 13. Br J Dermatol. 2008. PMID: 18341665 Clinical Trial.
Cited by
-
Acne Vulgaris, Atopic Dermatitis and Rosacea: The Role of the Skin Microbiota-A Review.Biomedicines. 2022 Oct 9;10(10):2523. doi: 10.3390/biomedicines10102523. Biomedicines. 2022. PMID: 36289784 Free PMC article. Review.
-
Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis.Acta Derm Venereol. 2022 Aug 24;102:adv00764. doi: 10.2340/actadv.v102.2075. Acta Derm Venereol. 2022. PMID: 35818735 Free PMC article.
-
Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis.Immunotargets Ther. 2020 Nov 10;9:255-272. doi: 10.2147/ITT.S229667. eCollection 2020. Immunotargets Ther. 2020. PMID: 33204661 Free PMC article. Review.
-
Halting the March: Primary Prevention of Atopic Dermatitis and Food Allergies.J Allergy Clin Immunol Pract. 2020 Mar;8(3):860-875. doi: 10.1016/j.jaip.2019.12.005. J Allergy Clin Immunol Pract. 2020. PMID: 32147139 Free PMC article.
-
Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection.J Allergy Clin Immunol Pract. 2020 Jan;8(1):91-101. doi: 10.1016/j.jaip.2019.06.044. Epub 2019 Aug 29. J Allergy Clin Immunol Pract. 2020. PMID: 31474543 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical